Home › Funds › Lynx1 Capital Management LP › TRAW

Lynx1 Capital Management LP position in TRAW

Traws Pharma Inc · Health Care

Lynx1 Capital Management LP reported holding 559,470 shares of TRAW (Traws Pharma Inc) in its Q2 2026 13F filing — a position valued at US$472K, representing 0.05% of its reported portfolio and ranking #16 among its reported holdings. Lynx1 Capital Management LP has disclosed TRAW holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)559.47K sh
Reported value held$471.80K
Portfolio Weight0.05%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's TRAW position evolved

Lynx1 Capital Management LP first disclosed a stake in TRAW in Q1 2026 at 15,078 shares (US$28K). The position peaked in Q2 2026 at 559,470 shares, worth US$472K. Across 2 filings, Lynx1 Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 559,470 shares valued at US$472K — an increase of 544,392 shares quarter over quarter.. Notable position changes include a 3611% increase in Q2 2026 (shares fell 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 15.08K $27.59K New
Q2 2026 559.47K $471.80K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRAW and 13F data

TRAW (Traws Pharma Inc) is a Health Care company. 36 other funds we track also report a position in TRAW — the largest reported positions include Ally Bridge Group (NY) LLC (US$663K), Kynam Capital Management, LP (US$71K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRAW

All TRAW fund holders →

FAQ

How long has Lynx1 Capital Management LP held TRAW?

Lynx1 Capital Management LP has disclosed TRAW holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Lynx1 Capital Management LP's current position in TRAW?

As of Q2 2026, Lynx1 Capital Management LP holds 559.47K shares of TRAW (Traws Pharma Inc), valued at $471.80K, representing 0.05% of its reported portfolio and ranking #16.

Has Lynx1 Capital Management LP been buying or selling TRAW?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP increased its position in TRAW. The position peaked in Q2 2026 at 559.47K shares.

Which other funds hold TRAW?

Other major institutional holders of TRAW include Ally Bridge Group (NY) LLC, Kynam Capital Management, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.